SC
WVE icon

Sculptor Capital’s Wave Life Sciences WVE Stock Holding History

Sculptor Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-120,200
Closed -$1.25M – 378
2020
Q2 		$1.25M Hold
120,200
– – 0.01% 203
2020
Q1 		$1.13M Buy
+120,200
New +$1.02M 0.02% 152

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sculptor Capital's WVE Position: Q3 2020 in Review

Sculptor Capital sold out of Wave Life Sciences (WVE) in Q3 2020, closing a stake of 120,200 shares — an estimated $1.25M sold.

Sculptor Capital first reported a position in WVE in Q1 2020 and held it in 2 quarters. The position peaked at $1.25M in Q2 2020. 110 funds tracked by Wall St. Rank hold WVE as of Q3 2020.

  • Sculptor Capital reported no remaining Wave Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Sculptor Capital sold 120,200 Wave Life Sciences shares in Q3 2020, an estimated $1.25M.
  • Sculptor Capital first reported a position in Wave Life Sciences in Q1 2020 and held it in 2 quarters.
  • Sculptor Capital's Wave Life Sciences position peaked at $1.25M in Q2 2020.
  • 110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2020.

Based on Sculptor Capital's 13F filing for Q3 2020, filed 12 Nov 2020.